| AB SICAV I-SELECT US EQUITY PORTFOLIO A EUR H | RVI USA | 12,23% | 51,66% | 49,73% | 160,15% |
| DWS ESG AKKUMULA ID | RVI GLOBAL | 10,97% | 43,79% | 51,71% | 160,15% |
| JANUS HENDERSON GLOBAL LIFE SCIENCES I2 EUR | BIOTECNOLOGÍA | 10,23% | 23,29% | 37,96% | 160,15% |
| ROBECO BP US PREMIUM EQUITIES F USD | RVI USA VALOR | 4,19% | 31,04% | 52,05% | 160,15% |
| GOLDMAN SACHS GLOBAL EQUITY PARTNERS ESG PORTFOLIO IO H USD CAP | RVI GLOBAL | 1,45% | 20,72% | 32,55% | 160,11% |
| MAGALLANES VALUE INVESTORS UCITS-EUROPEAN EQUITY-I | RVI EUROPA | 22,25% | 35,84% | 73,48% | 160,10% |
| GOLDMAN SACHS US SMALL CAP CORE EQUITY PORTFOLIO BASE (CLOSE) USD CAP | RVI USA SMALL/MID CAP | 21,95% | 48,93% | 42,91% | 159,92% |
| GOLDMAN SACHS US SMALL CAP CORE EQUITY PORTFOLIO I (SNAP) USD DIS | RVI USA SMALL/MID CAP | 22,45% | 49,82% | 43,34% | 159,92% |
| ROBECO BP US PREMIUM EQUITIES F EUR | RVI USA VALOR | 3,85% | 30,64% | 51,87% | 159,83% |
| INVESCO JAPANESE EQUITY ADVANTAGE A CAP EUR (HEDGED) | RVI JAPÓN | 26,15% | 57,61% | 58,33% | 159,82% |
